AstraZeneca - About the company
AstraZeneca is an unfunded company based in Shanghai (China), founded in 1999. It operates as a Diversified pharmaceutical company. AstraZeneca has not raised any funding yet. The company has 1702 active competitors, including 83 funded and 177 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.
Company Details
- Website
- www.astrazeneca.com.cn/zh
- Registered Address
- Block A, Neville Tower, 11th Floor Ramanujan IT SEZ, Taramani, Chennai, Chennai, Tamil Nadu, India, 600113
Legal entities associated with AstraZeneca
AstraZeneca is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ALEXION BUSINESS SERVICES PRIVATE LIMITED CIN: U74120MH2011PTC218281 , India, Active | Jun 03, 2011 | 0 - ₹10 Cr (As on Mar 31, 2024) | 2 (As on Jun 30, 2023) | |
ASTRAZENECA INDIA PRIVATE LIMITED CIN: U24111TN1986PTC123423 , India, Active | Jan 06, 1986 | ₹1,000+ Cr (As on Mar 31, 2025) | 4307 (As on Aug 01, 2025) |
Sign up to download AstraZeneca's company profile
AstraZeneca's funding and investors
AstraZeneca has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
AstraZeneca's Competitors and alternates
Top competitors of AstraZeneca include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of AstraZeneca, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AbbVie 2012, Chicago (United States), Public | Research-based biopharmaceutical company | $14.7B | 81/100 | |
2nd | Amgen 1980, Thousand Oaks (United States), Public | Developer of pharmaceutical products for treating multiple diseases | - | 81/100 | |
3rd | Gilead 1987, Foster City (United States), Acquired | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | - | 80/100 | |
4th | Lilly 1876, Indianapolis (United States), Public | Developer of traditional pharmaceutical medicines | - | 79/100 | |
5th | Johnson & Johnson 1886, New Brunswick (United States), Public | Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products | - | 76/100 | |
6th | AstraZeneca 1999, Shanghai (China), Unfunded | Diversified pharmaceutical company | - | - | 24/100 |
7th | Roivant Sciences 2014, New York City (United States), Public | Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases | $1.3B | 72/100 | |
8th | ![]() Regeneron Pharmaceuticals 1988, Tarrytown (United States), Public | Developer of antibodies for the treatment of cancer, eye diseases, inflammatory diseases & others | - | 71/100 | |
9th | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
10th | Roche 1896, Basel (Switzerland), Public | Developer of pharmaceuticals and diagnostics kits | - | 70/100 |
Looking for more details on AstraZeneca's competitors? Click here to see the top ones
AstraZeneca's Investments and acquisitions
AstraZeneca has made 2 investments in Cholesgen and Axbio. AstraZeneca has not made any acquisitions as of now.News related to AstraZeneca
•
Kelan Pharma secures $14M+ to develop cholesterol-lowering drugs.Eastmoney•Feb 22, 2025•Cholesgen, DIC, Gaorong Capital, SDIC Venture Capital Management and 1 other
•
•
•
Are you a Founder ?
FAQs about AstraZeneca
Explore our recently published companies
- Fabric - San Francisco based, 2022 founded, Funding Raised company
- Ambit Equity - Munich based, 2021 founded, Unfunded company
- A Malgam Technologies - Quebec City based, 2016 founded, Funding Raised company
- Billbo - Visakhapatnam based, Unfunded company
- Sooq Al Thahab - Manama based, 2022 founded, Funding Raised company
- Second Ocean - South Korea based, 2025 founded, Funding Raised company
_1568184419567.png?format=webp&height=120&width=120)
